-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $33 FROM $60

Reuters·09/03/2026 10:46:47

Please log in to view news